Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...
Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...
Medical technology firm Brainlab AG has asked for bank proposals for its potential initial public offering in Frankfurt, ...
Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in ...
Smithfield Foods on Monday made public its paperwork for its New York initial public offering as the maker of Farmland bacon ...
Nice One Beauty Digital Marketing Co. surged in its debut after a $320 million initial public offering in Riyadh, the latest ...
Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...
The Quadrant Future Tek IPO was subscribed 48.99 times as of 5:00 PM IST on the second day of its offering, according to data ...
Although 2024 was an exceptionally lackluster year for new public offerings, the IPO market could gain momentum in 2025. In ...
(Reuters) -Oilfield services provider Flowco Holdings on Tuesday said it is seeking a valuation of up to $2 billion in its ...
Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.
Proceeds from the initial public offering (IPO) will be used to repay debt, redeem equity interests and support general ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback